IHealthScreen hauled in FDA 510(k) clearance for its AI-powered diagnostic that detects mild diabetic retinopathy in diabetic ...

HealthScreen, Inc., a healthcare AI company developing Software as a Medical Device (SaMD) for retinal and cardiovascular disease screening and preventive healthcare, today announced FDA 510(k) ...

Background/Aims Retinopathy of prematurity (ROP) zone classification guides disease severity assessment and Early Treatment ...

Somewhere, a 17-year-old has built an artificial intelligence tool designed to identify malaria and other blood diseases from microscope images faster than traditional methods allow. The project, ...

MOHSIN AKRAM is a passionate and results-driven professional with a solid foundation in programming, research, and data analysis, with over 3 years of experience in various roles, including Research ...

Abstract: Color fundus photography (CFP) is the most common ophthalmic imaging modality for large-scale screening. However, it is highly susceptible to degradations, making robust fundus image quality ...

These authors contributed equally to this work as first author. Non-communicable diseases (NCDs) account for over 60% of annual global deaths, disproportionately affecting low- and middle-income ...

The company's software analyses images captured by the iCare DRSplus camera, a tool widely used in ophthalmology clinics and ...

DR, an AI-powered screening software designed to detect more than mild diabetic retinopathy in adults with diabetes, ...

Fluorescein angiography may help evaluate retinal ischemia in long-standing type 2 diabetes and proliferative diabetic retinopathy.

Incorporation of an artificial intelligence based-optical coherence tomography (AI-OCT) system as a secondary screening tool is noninferior to standard practice and can reduce unnecessary diabetic ...

Researchers evaluated the utility of expanded-field OCT angiography as a primary screening tool for diabetic retinopathy.